NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
Net Income ContractionContracting
Percentile Rank93
3Y CAGR+29.6%
5Y CAGR+28.7%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+29.6%/yr
vs +2.6%/yr prior
5Y CAGR
+28.7%/yr
Consistent
Acceleration
+27.0pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.57B | -17.4% |
| 2025 | $18.85B | +35.8% |
| 2024 | $13.88B | +94.1% |
| 2023 | $7.15B | +320.8% |
| 2022 | $1.70B | -61.4% |
| 2021 | $4.41B | -4.3% |
| 2020 | $4.61B | -28.5% |
| 2019 | $6.44B | -7.4% |
| 2018 | $6.96B | +43.3% |
| 2017 | $4.86B | - |